![](/images/graphics-bg.png)
Clinical Significance of Serum Hemeoxygenase-1 as a New Biomarker for the Patients with Interstitial Pneumonia
المؤلفون المشاركون
Kawana, Akihiko
Murohashi, Kota
Hara, Yu
Shinada, Kanako
Nagai, Kenjiro
Shinkai, Masaharu
Kaneko, Takeshi
المصدر
العدد
المجلد 2018، العدد 2018 (31 ديسمبر/كانون الأول 2018)، ص ص. 1-7، 7ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2018-11-22
دولة النشر
مصر
عدد الصفحات
7
التخصصات الرئيسية
الملخص EN
Background.
Serum hemeoxygenase-1 (HO-1) has been proposed to be a biomarker of lung disease activity and prognosis.
The present study aimed at evaluating whether HO-1 could be a useful marker for evaluating disease activity and predicting prognosis in patients with interstitial pneumonia (IP).
Materials and Methods.
Serum HO-1 levels of newly diagnosed or untreated patients with IP were measured at hospitalization.
We evaluated the relationships between serum HO-1 and other serum biomarkers, high resolution CT (HRCT) findings, and hospital mortality.
Results.
Twenty-eight patients with IP, including 14 having an acute exacerbation (AE) and 14 not having an AE, were evaluated.
The patients having an AE had significantly higher HO-1 levels than those not having an AE (53.5 ng/mL vs.
24.1 ng/mL; p<0.001), and the best cut-off level to discriminate between having an AE or not having an AE was 41.6 ng/mL.
Serum HO-1 levels were positively correlated with serum levels of surfactant protein-D (r=0.66, p<0.001) and the ground glass opacity score (calculated from HRCT; r=0.40, p=0.036).
Patients who subsequently died in hospital had presented with significantly higher HO-1 levels than those who did not die in hospital (64.8 ng/mL vs.
32.0 ng/mL; p=0.009).
Conclusion.
Serum HO-1 may serve as a useful biomarker for detecting AE or predicting hospital mortality in patients with IP.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Murohashi, Kota& Hara, Yu& Shinada, Kanako& Nagai, Kenjiro& Shinkai, Masaharu& Kawana, Akihiko…[et al.]. 2018. Clinical Significance of Serum Hemeoxygenase-1 as a New Biomarker for the Patients with Interstitial Pneumonia. Canadian Respiratory Journal،Vol. 2018, no. 2018, pp.1-7.
https://search.emarefa.net/detail/BIM-1151865
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Murohashi, Kota…[et al.]. Clinical Significance of Serum Hemeoxygenase-1 as a New Biomarker for the Patients with Interstitial Pneumonia. Canadian Respiratory Journal No. 2018 (2018), pp.1-7.
https://search.emarefa.net/detail/BIM-1151865
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Murohashi, Kota& Hara, Yu& Shinada, Kanako& Nagai, Kenjiro& Shinkai, Masaharu& Kawana, Akihiko…[et al.]. Clinical Significance of Serum Hemeoxygenase-1 as a New Biomarker for the Patients with Interstitial Pneumonia. Canadian Respiratory Journal. 2018. Vol. 2018, no. 2018, pp.1-7.
https://search.emarefa.net/detail/BIM-1151865
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1151865
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)